Literature DB >> 11749663

Circulating nitrite anions are a directly acting vasodilator and are donors for nitric oxide.

E A G Demoncheaux1, T W Higenbottam, P J Foster, C D R Borland, A P L Smith, H M Marriott, D Bee, S Akamine, M B Davies.   

Abstract

Inhaled nitric oxide (NO) is a pulmonary vasodilator, but also acts systemically, causing negative cardiac inotropic effects and a fall in systemic vascular resistance. Circulating metabolites of NO are presumed to be responsible. We questioned the role of nitrite anions and the manner in which they might contribute to these effects. Nitrite and nitrate anions coexist in blood, while circulating levels of dissolved NO are very low. Nitrate anions are not biologically active, but nitrite anions may have a biological role through the release of NO. In vitro, at 37 degrees C and in aerated Krebs bicarbonate solution, the steady-state concentration of dissolved NO was proportional to the concentration of NO in the gas. Nanomolar concentrations of dissolved NO coexisted with micromolar concentrations of nitrite anions. The idea of an equilibrium between the two in solution was also supported by the observed release of NO from nitrite anions in the absence of gas. With rings of precontracted pig pulmonary arteries (prostaglandin F(2alpha); 10 micromol/l), the steady-state concentration of dissolved NO causing 50% relaxation (EC(50)) was 0.84+/-0.25 nmol/l, corresponding to a gaseous concentration of 2.2 p.p.m. The EC(50) of nitrite was 4.5+/-0.7 micromol/l, a concentration normally found in plasma. The estimated concentration of dissolved NO derived from this nitrite was 4.5 pmol/l, some 100 times lower than would be needed to cause relaxation. The rate of exhalation of NO was increased and pulmonary vascular resistance was reduced by the addition of nitrite solution to the perfusate of isolated perfused and ventilated pig lungs, but only when millimolar concentrations were achieved. Thus circulating nitrite anions are a direct vasodilator, only being a carrier of effective amounts of "free" NO at higher than physiological concentrations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11749663

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  11 in total

Review 1.  Inorganic nitrite therapy: historical perspective and future directions.

Authors:  Christopher G Kevil; Gopi K Kolluru; Christopher B Pattillo; Tony Giordano
Journal:  Free Radic Biol Med       Date:  2011-05-04       Impact factor: 7.376

2.  Inhalation of NO during myocardial ischemia reduces infarct size and improves cardiac function.

Authors:  Nils Neye; Fabian Enigk; Sruti Shiva; Helmut Habazettl; Nikolaus Plesnila; Hermann Kuppe; Mark T Gladwin; Wolfgang M Kuebler
Journal:  Intensive Care Med       Date:  2012-06-01       Impact factor: 17.440

Review 3.  A physiologically relevant role for NO stored in vascular smooth muscle cells: A novel theory of vascular NO signaling.

Authors:  Taiming Liu; Hobe Schroeder; Gordon G Power; Arlin B Blood
Journal:  Redox Biol       Date:  2022-05-09       Impact factor: 10.787

4.  Renal hemodynamic and excretory responses to intra-arterial infusion of peroxynitrite in anesthetized rats.

Authors:  Luis C Matavelli; Philip J Kadowitz; L Gabriel Navar; Dewan S A Majid
Journal:  Am J Physiol Renal Physiol       Date:  2008-11-05

Review 5.  Nitrite as regulator of hypoxic signaling in mammalian physiology.

Authors:  Ernst E van Faassen; Soheyl Bahrami; Martin Feelisch; Neil Hogg; Malte Kelm; Daniel B Kim-Shapiro; Andrey V Kozlov; Haitao Li; Jon O Lundberg; Ron Mason; Hans Nohl; Tienush Rassaf; Alexandre Samouilov; Anny Slama-Schwok; Sruti Shiva; Anatoly F Vanin; Eddie Weitzberg; Jay Zweier; Mark T Gladwin
Journal:  Med Res Rev       Date:  2009-09       Impact factor: 12.944

6.  Vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric oxide pathway.

Authors:  Satnam Lidder; Andrew J Webb
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

7.  Evaluation of changes in central airway dimensions, lung area and mean lung density at paired inspiratory/expiratory high-resolution computed tomography.

Authors:  J R Ederle; C P Heussel; J Hast; B Fischer; E J R Van Beek; S Ley; M Thelen; H U Kauczor
Journal:  Eur Radiol       Date:  2003-06-14       Impact factor: 5.315

8.  Flavohemoglobin Hmp protects Salmonella enterica serovar typhimurium from nitric oxide-related killing by human macrophages.

Authors:  Tânia M Stevanin; Robert K Poole; Eric A G Demoncheaux; Robert C Read
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

Review 9.  Hypoxemia, oxygen content, and the regulation of cerebral blood flow.

Authors:  Ryan L Hoiland; Anthony R Bain; Mathew G Rieger; Damian M Bailey; Philip N Ainslie
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-12-16       Impact factor: 3.619

10.  Nitrergic response to cyclophosphamide treatment in blood and bone marrow.

Authors:  Kevorkian G A; Alchujyan N Kh; Movsesyan N H; Hayrapetyan H L; Guevorkian A G; Ohanyan R M; Dagbashyan S S
Journal:  Open Biochem J       Date:  2008-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.